Sequoia Financial Advisors LLC Has $16.76 Million Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Sequoia Financial Advisors LLC grew its holdings in IQVIA Holdings Inc. (NYSE:IQV) by 13.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 85,299 shares of the medical research company’s stock after purchasing an additional 10,245 shares during the period. Sequoia Financial Advisors LLC’s holdings in IQVIA were worth $16,762,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in IQV. Synergy Asset Management LLC acquired a new position in IQVIA during the fourth quarter worth $33,000. Avior Wealth Management LLC increased its holdings in IQVIA by 117.6% during the third quarter. Avior Wealth Management LLC now owns 161 shares of the medical research company’s stock worth $38,000 after buying an additional 87 shares during the last quarter. Assetmark Inc. increased its holdings in IQVIA by 612.5% during the third quarter. Assetmark Inc. now owns 228 shares of the medical research company’s stock worth $54,000 after buying an additional 196 shares during the last quarter. Ashton Thomas Securities LLC acquired a new position in IQVIA during the third quarter worth $57,000. Finally, Meeder Asset Management Inc. increased its holdings in IQVIA by 353.7% during the third quarter. Meeder Asset Management Inc. now owns 245 shares of the medical research company’s stock worth $58,000 after buying an additional 191 shares during the last quarter. 89.62% of the stock is currently owned by institutional investors and hedge funds.

IQVIA Trading Up 1.1 %

IQV opened at $185.47 on Thursday. IQVIA Holdings Inc. has a twelve month low of $179.28 and a twelve month high of $261.72. The company has a 50-day simple moving average of $197.14 and a 200 day simple moving average of $211.59. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 2.12. The stock has a market capitalization of $32.70 billion, a price-to-earnings ratio of 24.73, a P/E/G ratio of 1.99 and a beta of 1.50.

IQVIA (NYSE:IQV) last posted its quarterly earnings data on Thursday, February 6th. The medical research company reported $2.90 earnings per share for the quarter, missing the consensus estimate of $3.11 by ($0.21). IQVIA had a return on equity of 28.81% and a net margin of 8.91%. Analysts predict that IQVIA Holdings Inc. will post 10.84 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Stifel Nicolaus lowered their target price on shares of IQVIA from $273.00 to $261.00 and set a “buy” rating on the stock in a report on Friday, February 7th. BTIG Research downgraded shares of IQVIA from a “buy” rating to a “neutral” rating in a report on Monday, February 3rd. UBS Group decreased their price objective on shares of IQVIA from $260.00 to $255.00 and set a “buy” rating on the stock in a report on Friday, February 7th. Bank of America decreased their price objective on shares of IQVIA from $255.00 to $235.00 and set a “buy” rating on the stock in a report on Friday, December 13th. Finally, Stephens assumed coverage on shares of IQVIA in a report on Friday, December 20th. They issued an “overweight” rating and a $250.00 price objective on the stock. Five equities research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $249.05.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.